Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Advisory Panel Considers Trial Designs For Community Acquired Pneumonia

Jan 16 2008

• By Becky Jungbauer

Related Content

FDA Anti-Infective Drugs Advisory Committee To Review Two Antibiotics

Jan 10 2008

Pfizer Receives “Approvable” Letter For MRSA Antibiotic Dalbavancin

Dec 21 2007

Wyeth’s Tygacil sNDA For Community-Acquired Pneumonia Accepted By FDA

Oct 24 2007

J&amp;J, Basilea To Base Ceftobiprole Filing For Hospital-Acquired Pneumonia On Phase III Results

Oct 09 2007

Advanced LifeSciences Confirms Efficacy Of Cethromycin In Second Phase III Trial

Nov 15 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window